Φορτώνει......
Current evidence and controversies in the incorporation of biologics for metastatic colorectal cancer
With the advent of new drugs and therapeutic combinations for metastatic colorectal cancer, the prognosis for this often incurable disease is improving. In addition to traditional cytotoxic chemotherapeutics, targeted biologic therapies, such as cetuximab, panitumumab, bevacizumab, aflibercept and r...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Hepat Oncol |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Future Medicine Ltd
2014
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6095158/ https://ncbi.nlm.nih.gov/pubmed/30190967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep.14.13 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|